News Archive

Dec 2016

Dec 22, 2016 Starpharma receives $3.5M R&D tax incentive refund

Nov 2016

Nov 29, 2016 AGM Chairman’s address and CEO presentation

Nov 28, 2016 Starpharma signs license for VivaGel® Condom in Iran

Nov 08, 2016 Starpharma to present at Bio-Europe conference

Oct 2016

Oct 28, 2016 Appendix 4C - Quarterly Cashflow Report

Oct 28, 2016 Additional Priostar® Glyphosate Patent Allowed in US

Oct 26, 2016 Starpharma to present at US Drug Delivery Conference

Oct 25, 2016 Starpharma to present at ASX Spotlight in Asia

Oct 13, 2016 Enrolment complete for Phase 3 VivaGel® BV-R program

Sep 2016

Sep 13, 2016 VivaGel® condom receives regulatory approval in Canada

Aug 2016

Aug 30, 2016 Highlights of FY2016 Presentation: FNN Interview

Aug 29, 2016 Annual Report and full year financial results

Aug 01, 2016 The Australian: Starpharma perks up on China condom deal

Jul 2016

Jul 28, 2016 Starpharma initiates new DEP™ drug delivery program with AstraZeneca

Jul 21, 2016 Starpharma signs license for a VivaGel® condom in China

Jul 14, 2016 Appendix 4C - Quarterly Cashflow Report

May 2016

May 25, 2016 Starpharma’s DEP™ eliminates cabazitaxel neutropenia

May 17, 2016 The Conversation: Antiviral condoms will help protect Australian Olympians from STIs – here’s how

May 17, 2016 Starpharma to present at ASX CEO Session

May 16, 2016 Australian Olympic Team taking Dual Protect™ VivaGel® Condoms to Rio

May 05, 2016 VivaGel® active against Zika virus

Apr 2016

Apr 28, 2016 Appendix 4C - Quarterly Cashflow Report

Apr 13, 2016 Shareholder Update April 2016

Apr 05, 2016 Starpharma to present at Bio-Europe conference

Apr 04, 2016 DEP cabazitaxel shows complete and sustained tumour regression in breast cancer model

Mar 2016

Mar 17, 2016 Adama Licenses Starpharma's Priostar for Novel 2,4-D

Mar 09, 2016 AAP: Starpharma licenses VivaGel BV in Aust, NZ

Mar 04, 2016 Starpharma licences VivaGel® BV to Aspen for ANZ

Feb 2016

Feb 17, 2016 Interim Report and Half-Yearly Financial Results

Feb 02, 2016 Targeted DEP™ shows sustained superior performance

Jan 2016

Jan 28, 2016 Appendix 4C - Quarterly Cashflow Report

Jan 20, 2016 Starpharma raises $1.9M under Share Purchase Plan